Acute Myeloblastic Leukemia Type 3 Companies - LARVOL Sigma

Acute Myeloblastic Leukemia Type 3

Welcome, Profile Billing Logout

0 Mechanisms of Action


Phase N/A 1 2 3 4 Products		0	5										10										15										20										25										30										35										40										45										50



Generic mfg.



Pfizer



BMS



Merck (MSD)



Novartis



AstraZeneca



Bausch Health



Kyowa Kirin



National Cancer Institute



Seagen



AEterna Zentaris



AbbVie



Aceragen



Akebia Therap



Allarity Therap



Amgen



ArchiMed



Assertio



Astellas



Aurobindo



Bayer



Clinigen



Cytokinetics



Deverra Therapeutics



EMD Serono



EOC Pharma



EddingPharm



Incyte



Iovance Biotherap



J&J



Kura Oncology



Leadiant Biosci



Mundipharma



Nippon Kayaku



Nippon Shinyaku



Nohla Therap



Northwestern University



Ohara Pharma



Ono Pharma



Otsuka



PDL



Partner Therap



Pharmascience



Prometheus



R-Pharm



RaQualia



Roche



SOBI



Sanofi



Spectrum Pharma